Novmetapharma Co., Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Sep 2033
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 21, 2027The maintenance fee for Polymorphic forms of Cyclo (-His-Pro) and methods of use to treat kidney disease (US 11,820,834) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
- 1 fee due Jun 26, 2027The maintenance fee for Method for Treatment of Cytokine Release Syndrome (US 11,850,246) comes due Jun 26, 2027. Unpaid by Dec 27, 2027, it lapses early.
- 1 fee due Aug 6, 2027The maintenance fee for Cell-protecting composition containing cyclo histidine-proline as active ingredient (US 11,890,317) comes due Aug 6, 2027. Unpaid by Feb 7, 2028, it lapses early.
- 1 fee due Nov 7, 2027The maintenance fee for Composition comprising CHP (cyclo-his pro) for preventing, improving or treating of bone loss related disease (US 11,975,041) comes due Nov 7, 2027. Unpaid by May 8, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,675,580 | Method of treatment for enhancing exercise performance In force · From the USPTO record | In force | From the USPTO record | |
| US 10,792,280 | Pharmaceutical Composition Comprising Amodiaquine and Anti-Diabetes Drug as Effective Ingredient for Prevention or Treatment of Diabetes In force · High confidence | In force | High confidence | |
| US 10,934,303 | Novel Aryl Ethene Derivative and Pharmaceutical Composition Containing Same as Active Ingredient In force · High confidence | In force | High confidence | |
| US 10,918,693 | Composition for cell protection containing cyclo histidine-proline as active ingredient In force · From the USPTO record | In force | From the USPTO record | |
| US 11,433,114 | Composition for cell protection containing cyclo histidine-proline as active ingredient In force · From the USPTO record | In force | From the USPTO record | |
| US 11,890,317 | Cell-protecting composition containing cyclo histidine-proline as active ingredient In force · From the USPTO record | In force | From the USPTO record | |
| US 11,607,441 | Pharmaceutical Composition for Preventing or Treating Diabetes, Containing Zinc Salt, Cyclo-Hispro and Antidiabetic Drug as Active Ingredients In force · High confidence | In force | High confidence | |
| US 11,975,041 | Composition comprising CHP (cyclo-his pro) for preventing, improving or treating of bone loss related disease In force · From the USPTO record | In force | From the USPTO record | |
| US 11,273,196 | Antithrombotic composition containing Polygonum cuspidatum sieb. et zucc. and Cinnamomum cassia blume In force · From the USPTO record | In force | From the USPTO record | |
| US 10,683,300 | Polymorphic forms of Cyclo (-His-Pro) In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 20: 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
8 pending · 3 abandoned · 3 no status recorded